Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study.
Valenza C, Trapani D, Zagami P, Antonarelli G, Boscolo Bielo L, Nicolò E, Ribeiro JM, Guidi L, Reduzzi C, Spotti M, Adamoli L, Cortès J, Pistilli B, Tolaney SM, Ueno N, Layman RM, Cristofanilli M, Carey LA, Munzone E, Criscitiello C, Lynce F, Woodward WA, Curigliano G. Valenza C, et al. Among authors: reduzzi c. Eur J Cancer. 2024 Oct 28;213:115097. doi: 10.1016/j.ejca.2024.115097. Online ahead of print. Eur J Cancer. 2024. PMID: 39486164
Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of FGFR2-KIAA1598 Gene Fusion.
Nicolò E, Munoz-Arcos L, Vagia E, D'Amico P, Reduzzi C, Donahue J, Lorico-Rappa M, Manai M, Behdad A, Zhang Y, Curigliano G, Shah A, Cristofanilli M. Nicolò E, et al. Among authors: reduzzi c. JCO Precis Oncol. 2023 Jul;7:e2200702. doi: 10.1200/PO.22.00702. JCO Precis Oncol. 2023. PMID: 37437229 No abstract available.
Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer.
Shah AN, Carroll KJ, Gerratana L, Lin C, Davis AA, Zhang Q, Jacob S, Finkelman B, Zhang Y, Qiang W, D'Amico P, Reduzzi C, Gradishar WJ, Behdad A, Cristofanilli M. Shah AN, et al. Among authors: reduzzi c. Breast Cancer Res Treat. 2021 Jun;187(2):397-405. doi: 10.1007/s10549-021-06236-1. Epub 2021 Jun 2. Breast Cancer Res Treat. 2021. PMID: 34076801
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis.
Gerratana L, Davis AA, Velimirovic M, Reduzzi C, Clifton K, Bucheit L, Hensing WL, Shah AN, Pivetta T, Dai CS, D'Amico P, Wehbe F, Medford A, Wander SA, Gradishar WJ, Behdad A, Ma CX, Puglisi F, Bardia A, Cristofanilli M. Gerratana L, et al. Among authors: reduzzi c. JCO Precis Oncol. 2023 May;7:e2200531. doi: 10.1200/PO.22.00531. JCO Precis Oncol. 2023. PMID: 37141549 Free PMC article.
43 results